These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36198202)

  • 21. Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops.
    Li J; Zeng L; Xie J; Yue Z; Deng H; Ma X; Zheng C; Wu X; Luo J; Liu M
    Sci Rep; 2015 Dec; 5():17605. PubMed ID: 26620037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
    Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
    J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
    Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy proteins regulate the secretory component of osteoclastic bone resorption.
    DeSelm CJ; Miller BC; Zou W; Beatty WL; van Meel E; Takahata Y; Klumperman J; Tooze SA; Teitelbaum SL; Virgin HW
    Dev Cell; 2011 Nov; 21(5):966-74. PubMed ID: 22055344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
    Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
    J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRAF6/ERK/p38 pathway is involved in interleukin-17-mediated autophagy to promote osteoclast precursor cell differentiation.
    Shen Y; Wang Z; Tan J; Zhong J; Chen L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 50(2):162-170. PubMed ID: 34137231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process.
    Hong H; Shi Z; Qiao P; Li H; McCoy EM; Mao P; Xu H; Feng X; Wang S
    Biochem Biophys Res Commun; 2013 Nov; 440(4):545-50. PubMed ID: 24103757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway.
    Zhang Q; Hu S; He Y; Song Z; Shen Y; Zhao Z; Zhang Q; Qin L; Zhang Q
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
    Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.
    Flanagan AM; Massey HM; Wilson C; Vellodi A; Horton MA; Steward CG
    Bone; 2002 Jan; 30(1):85-90. PubMed ID: 11792569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway.
    Li Y; Zhuang Q; Tao L; Zheng K; Chen S; Yang Y; Feng C; Wang Z; Shi H; Shi J; Fang Y; Xiao L; Geng D; Wang Z
    Cell Prolif; 2022 Oct; 55(10):e13291. PubMed ID: 35708050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells.
    Song C; Yang X; Lei Y; Zhang Z; Smith W; Yan J; Kong L
    J Cell Physiol; 2019 Jul; 234(7):11969-11975. PubMed ID: 30515780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Osteoclast Differentiation at Multiple Stages by Protein Kinase D Family Kinases.
    Leightner AC; Mello Guimaraes Meyers C; Evans MD; Mansky KC; Gopalakrishnan R; Jensen ED
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation of protein kinase C beta in osteoclast differentiation and function.
    Lee SW; Kwak HB; Chung WJ; Cheong H; Kim HH; Lee ZH
    Bone; 2003 Mar; 32(3):217-27. PubMed ID: 12667549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous Compressive Force Induces Differentiation of Osteoclasts with High Levels of Inorganic Dissolution.
    Matsuike R; Nakai K; Tanaka H; Ozaki M; Kanda M; Nagasaki M; Shibata C; Mayahara K; Tanabe N; Koshi R; Nakajima A; Kawato T; Maeno M; Shimizu N; Motoyoshi M
    Med Sci Monit; 2019 May; 25():3902-3909. PubMed ID: 31129676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cytokines in inflammatory bone loss.
    Souza PP; Lerner UH
    Immunol Invest; 2013; 42(7):555-622. PubMed ID: 24004059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.